Clorox reported $6.72B of revenue over the trailing twelve months, −5.4% on the year before. 9 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $6.72B (to Q4 2026). Net income: $587M, trailing twelve months to Q4 2026. Free cash flow: $405M, trailing twelve months to Q4 2026. EPS: $4.82, trailing twelve months to Q4 2026.

CLXClorox

Consumer Defensive

$86.39-24% 1Y

$86.39

$80.4152 weeks$125.58

CLX as reported

Clorox reported $6.72B of revenue over the trailing twelve months, −5.4% on the year before. 9 reported series are charted on this page, each one as filed.

$6.72B

Revenue, trailing twelve months · to Q4 2026 · −5.4% against the twelve months before

Net income: $587M
Net income · −28% year on year · trailing twelve months to Q4 2026
Free cash flow: $405M
Free cash flow · −47% year on year · trailing twelve months to Q4 2026
EPS: $4.82
EPS · −26% year on year · trailing twelve months to Q4 2026

Details›

Every series Ryufin has for CLX, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$6.72B	−5.4%	Q4 2026
Net income	$587M	−28%	Q4 2026
EPS	$4.82	−26%	Q4 2026
Gross margin	42%	n/a	Q4 2026
Net margin	8.6%	n/a	Q4 2026
ROE	−1169%	n/a	Q4 2026
ROA	12%	n/a	Q4 2026
Free cash flow	$405M	−47%	Q4 2026
P/E	17.9	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.